Micro- and Nanoparticles for Treating Cardiovascular Disease. - Wikidata - awgldk - TriplyDB

Micro- and Nanoparticles for Treating Cardiovascular Disease.

Micro- and Nanoparticles for Treating Cardiovascular Disease.

http://www.wikidata.org/entity/Q35801354

about

Neuropeptide Y3-36 incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia.Intramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagation Formulation and In vitro Interaction of Rhodamine-B Loaded PLGA Nanoparticles with Cardiac Myocytes.The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction Enzyme-Targeted Nanoparticles for Delivery to Ischemic Skeletal Muscle.Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease.Cancer imaging using surface-enhanced resonance Raman scattering nanoparticles.Influence of cell size on cellular uptake of gold nanoparticles.Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment.Exosome-like silica nanoparticles: a novel ultrasound contrast agent for stem cell imaging.Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.

P2860

Q36311441-500D6463-F919-460A-A44D-A250945D0411 Q36635288-A8ECDA72-AA17-4D0C-932C-04CD90340B3F Q37474952-3016C65B-F36C-4EF6-BF0B-6A19FC41598B Q38775962-CA07F45F-2B36-40BE-B852-1AC243C9A8A3 Q41295473-FA0E9C18-D87D-44B9-95DB-D2A86826321F Q46269755-13BE2DBA-D26F-4464-87A4-529E319E083D Q46813976-E5CF1B81-193B-4AC8-BB5D-6027F4A003C6 Q47162415-7D7A74FF-5B5C-4A20-A7BB-185E4383D3D2 Q47310068-D49E001C-66CF-4E7D-8238-23D2E6F6E2C4 Q49263652-58B02031-70FE-43C5-A652-509323EE0ED5 Q49404531-1BC13B84-ACD1-400A-90FD-AD35A6E9D87B Q51735768-4860B661-20A7-4B16-BF9A-F8FDEC3EF5A9

P2860

Micro- and Nanoparticles for Treating Cardiovascular Disease.

http://www.wikidata.org/entity/Q35801354

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@ast

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@en

type

label

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@ast

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@en

prefLabel

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@ast

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@en

P1433

Q35801354-B26187E2-621D-448E-9EAD-A322ACC8549A

P1476

Q35801354-0DD27B7E-6C2A-40F5-A610-E677EA15F58C

P2093

Q35801354-A4E0F100-096B-477D-A7E2-F0CBC9C0F544

Q35801354-AE939EA7-B28C-4745-BF52-141400B3CD1F

Q35801354-C56332EE-7794-4CFB-8D17-83CBA85D87FC

P2860

Q35801354-02EE6057-73FC-4B1D-A25B-6C0D980B2C47

Q35801354-0BBE41B6-87D3-4398-8611-28F55E0E6A26

Q35801354-0C3E4873-E832-4A8C-B490-89A9518C357A

Q35801354-0C4D0853-E521-43C6-9E1F-49EBC346F82B

Q35801354-0DFDDDB3-BB0D-4EAF-9A50-D87B624F7AF7

Q35801354-0E43D809-44F8-4784-852C-74EAA4C9AC3D

Q35801354-161EF4DE-5AA8-400B-9341-5633B6EA605A

Q35801354-186DE2BF-D358-406B-ADA4-CA2F5B7AEE8E

Q35801354-1E1A85E3-F9C0-4D38-966D-CA859313D936

Q35801354-22CF13C8-01C7-425F-8513-09A0BC5B5FC0

P304

Q35801354-254C5EDC-BB71-4EED-A51F-896467885069

P31

Q35801354-558A57D8-27DB-4A3F-915E-0B488CCFED85

P356

Q35801354-2AA60630-F1AE-4911-9B21-B25538A46BC5

P433

Q35801354-DF56014A-EF49-4F53-93C8-DA71AA84C7A2

P478

Q35801354-6AF87B70-ECE6-4480-9149-50643DA8BD6B

P577

Q35801354-6D68B635-89F5-47FE-A503-39E2443AFFAA

P698

Q35801354-6AF3C308-47FF-4E66-A7F0-D79085C2F487

P932

Q35801354-72C94BD8-0395-4A07-A9D3-5B61427BCD6B

P356

P1433

Biomaterials Science

P1476

Micro- and Nanoparticles for Treating Cardiovascular Disease.

@en

P2093

A Almutairi

http://www.w3.org/2001/XMLSchema#string

K L Christman

http://www.w3.org/2001/XMLSchema#string

S Suarez

http://www.w3.org/2001/XMLSchema#string

P2860

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction

Medical treatment of peripheral arterial disease

Peripheral arterial disease detection, awareness, and treatment in primary care

Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction

Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.

Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.

P304

564-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C4BM00441H

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26146548

http://www.w3.org/2001/XMLSchema#string

P932

4486363

http://www.w3.org/2001/XMLSchema#string